Literature DB >> 21143308

Small RNAs promote mRNA stability to activate the synthesis of virulence factors.

Dimitri Podkaminski1, Jörg Vogel.   

Abstract

Although most bacterial small RNAs act to repress target mRNAs, some also activate messengers. The predominant mode of activation has been seen in 'anti-antisense' regulation whereby a small RNA prevents the formation of an inhibitory 5' mRNA structure that otherwise impairs translational initiation and protein synthesis. The translational activation might also stabilize the target yet this was considered a secondary effect in the examples known thus far. Two recent papers in Molecular Microbiology investigate post-transcriptional activation of collagenase mRNA by Clostridium VR-RNA, and streptokinase mRNA by Streptococcus FasX RNA, to suggest that small RNAs exert positive regulation of virulence genes primarily at the level of mRNA stabilization.
© 2010 Blackwell Publishing Ltd.

Mesh:

Substances:

Year:  2010        PMID: 21143308     DOI: 10.1111/j.1365-2958.2010.07428.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  14 in total

1.  RNAIII of the Staphylococcus aureus agr system activates global regulator MgrA by stabilizing mRNA.

Authors:  Ravi Kr Gupta; Thanh T Luong; Chia Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

2.  The Vibrio parahaemolyticus small RNA RyhB promotes production of the siderophore vibrioferrin by stabilizing the polycistronic mRNA.

Authors:  Tomotaka Tanabe; Tatsuya Funahashi; Hiroshi Nakao; Jun Maki; Shigeo Yamamoto
Journal:  J Bacteriol       Date:  2013-06-14       Impact factor: 3.490

Review 3.  The alternative translational profile that underlies the immune-evasive state of persistence in Chlamydiaceae exploits differential tryptophan contents of the protein repertoire.

Authors:  Chien-Chi Lo; Gary Xie; Carol A Bonner; Roy A Jensen
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 4.  RNA-mediated regulation in Gram-positive pathogens: an overview punctuated with examples from the group A Streptococcus.

Authors:  Eric W Miller; Tram N Cao; Kathryn J Pflughoeft; Paul Sumby
Journal:  Mol Microbiol       Date:  2014-08-21       Impact factor: 3.501

5.  An in silico model for identification of small RNAs in whole bacterial genomes: characterization of antisense RNAs in pathogenic Escherichia coli and Streptococcus agalactiae strains.

Authors:  Christophe Pichon; Laurence du Merle; Marie Elise Caliot; Patrick Trieu-Cuot; Chantal Le Bouguénec
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

Review 6.  Genome-wide analyses of small non-coding RNAs in streptococci.

Authors:  Nadja Patenge; Roberto Pappesch; Afsaneh Khani; Bernd Kreikemeyer
Journal:  Front Genet       Date:  2015-05-20       Impact factor: 4.599

7.  Discovery of putative small non-coding RNAs from the obligate intracellular bacterium Wolbachia pipientis.

Authors:  Megan Woolfit; Manjula Algama; Jonathan M Keith; Elizabeth A McGraw; Jean Popovici
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

Review 8.  The Mechanisms of Virulence Regulation by Small Noncoding RNAs in Low GC Gram-Positive Pathogens.

Authors:  Stephanie Pitman; Kyu Hong Cho
Journal:  Int J Mol Sci       Date:  2015-12-14       Impact factor: 5.923

9.  An archaeal sRNA targeting cis- and trans-encoded mRNAs via two distinct domains.

Authors:  Dominik Jäger; Sandy R Pernitzsch; Andreas S Richter; Rolf Backofen; Cynthia M Sharma; Ruth A Schmitz
Journal:  Nucleic Acids Res       Date:  2012-09-10       Impact factor: 16.971

10.  Identification of novel growth phase- and media-dependent small non-coding RNAs in Streptococcus pyogenes M49 using intergenic tiling arrays.

Authors:  Nadja Patenge; André Billion; Peter Raasch; Jana Normann; Aleksandra Wisniewska-Kucper; Julia Retey; Valesca Boisguérin; Thomas Hartsch; Torsten Hain; Bernd Kreikemeyer
Journal:  BMC Genomics       Date:  2012-10-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.